Financial reports
ARS
2023 FY
Annual report to shareholders
27 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
20 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
19 Mar 24
8-K
Other Events
19 Mar 24
8-K
Other Events
14 Mar 24
8-K
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
8-K
Other Events
30 Jan 24
8-K
Company Logo Enhancing the Lives of Patients with Hematologic Malignancies Corporate Presentation January 2024
8 Jan 24
8-K
Entry into a Material Definitive Agreement
15 Dec 23
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results
2 Nov 23
8-K
Other Events
29 Sep 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
19 Mar 24
424B5
Prospectus supplement for primary offering
2 Nov 23
S-8
Registration of securities for employees
3 Aug 23
424B5
Prospectus supplement for primary offering
6 Jan 23
FWP
Free writing prospectus
5 Jan 23
424B5
Prospectus supplement for primary offering
4 Jan 23
S-3ASR
Automatic shelf registration
4 Jan 23
S-8
Registration of securities for employees
11 Aug 22
424B5
Prospectus supplement for primary offering
30 Mar 22
424B5
Prospectus supplement for primary offering
29 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
27 Mar 24
DEF 14A
Definitive proxy
27 Mar 24
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEF 14A
Definitive proxy
12 Apr 23
PRE 14A
Preliminary proxy
31 Mar 23
DEFA14A
Additional proxy soliciting materials
22 Mar 22
DEF 14A
Definitive proxy
22 Mar 22
DEFA14A
Additional proxy soliciting materials
22 Mar 21
DEF 14A
Definitive proxy
22 Mar 21
Other
SEC STAFF
SEC staff action: Order
5 Mar 21
SEC STAFF
SEC staff action: Order
4 Feb 21
EFFECT
Notice of effectiveness
9 Nov 20
CORRESP
Correspondence with SEC
4 Nov 20
CORRESP
Correspondence with SEC
9 Oct 20
CORRESP
Correspondence with SEC
7 Oct 20
UPLOAD
Letter from SEC
10 Sep 20
CT ORDER
Confidential treatment order
3 May 19
EFFECT
Notice of effectiveness
13 Jul 18
CORRESP
Correspondence with SEC
10 Jul 18
Ownership
4
Faye Feller
16 Feb 24
4
Anil Kapur
16 Feb 24
4
Scott Alan Samuels
16 Feb 24
4
MICHELLE ROBERTSON
16 Feb 24
4
ANDREW J GRETHLEIN
16 Feb 24
4
JOHN A SCARLETT
16 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
BlackRock Inc.
26 Jan 24